Modified PSMA ligands and uses related thereto
US6875886B2 · kind B2 · utility
113Cited by
13References
47Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 7, 2002 |
| Grant date | Apr 5, 2005 |
| Priority date | — |
| Expiry date | Jul 26, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57434
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The instant invention provides reagents and methods for diagnosis, detection and treatment of cancers (for example, prostate cancers). In particular, the invention provides methods to generate various functionalized PSMA ligands, and their uses in diagnosis, detection, imaging, and treatment of prostate cancers, especially those overexpressing PSMA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.